Topoisomerase IIα expression in mantle cell lymphoma: a marker of cell proliferation and a prognostic factor for clinical outcome
✍ Scribed by Schrader, C; Meusers, P; Brittinger, G; Teymoortash, A; Siebmann, J-U; Janssen, D; Parwaresch, R; Tiemann, M
- Book ID
- 110055912
- Publisher
- Nature Publishing Group
- Year
- 2004
- Tongue
- English
- Weight
- 191 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0887-6924
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract In mantle cell lymphoma (MCL), minimal residual disease (MRD) is an indicator of the disease outcome. Quantitative methods used so far do not provide a suitable molecular marker in 30–70% patients with MCL (depending on the technique used). We tested cyclin D1 as a marker for quantitati
## Abstract ## BACKGROUND Subcutaneous panniculitis‐like T‐cell lymphoma (SPTCL) is an uncommon type of skin lymphoma. The natural history, optimal treatment strategy, and prognostic factors associated with this malignancy are not well defined. ## METHODS The authors performed a systematic analy